This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results of the IFCT-1501 MAPS-2 clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting. The study was sponsored by the French Cooperative Thoracic Intergroup (IFCT) with drugs and […]
Research, Science and Treatments
Mesothelioma is best known as the cancer associated with exposure to asbestos. A lesser known fact about mesothelioma is that the period between the exposure/s to asbestos and the development of the cancer (known as the ‘latency period’) is incredibly long, ranging on average between 20 and 50 years. While the bulk of mesothelioma science […]
by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation
This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference, and observed a dynamic roundtable discussion about disparities in the medical field. As the conversation was first colored with various factors such as socioeconomic background and language barriers, the conversation took […]
With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over the amount previously available.
This particular funding is available through the Department of Defense’s Peer-Reviewed Cancer Research Program (PRCRP), a pot of funding available annually to researchers studying any one of […]
We recently spoke with mesothelioma nurse Colleen Norton, BSN, RN, of the University of Maryland to ask her some questions about her role in the field in honor of National Nurses Week and National Cancer Research Month. Here’s what she had to say:
At what institution do you work and what is your role there?
I work […]